Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

IMPORTANCE:  Three months of a once-weekly combination of rifapentine and isoniazid for treatment of latent tuberculosis...

BACKGROUND: The duration of protection against tuberculosis provided by isoniazid preventive therapy is not known for human...

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients with human...

Cavitation in tuberculosis enables highly efficient person-to-person aerosol transmission. We performed transcriptomics in the...

Objectives The anti-leprosy drug clofazimine has been shown to have antimicrobial activity against Mycobacterium...